Community Bank & Trust Waco Texas Acquires 44 Shares of UnitedHealth Group Incorporated $UNH

Community Bank & Trust Waco Texas raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,910 shares of the healthcare conglomerate’s stock after purchasing an additional 44 shares during the period. Community Bank & Trust Waco Texas’ holdings in UnitedHealth Group were worth $4,340,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 2.5% in the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the last quarter. Nuveen LLC purchased a new stake in UnitedHealth Group in the first quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after purchasing an additional 847,054 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.0%

Shares of UNH stock opened at $345.11 on Wednesday. The stock has a market cap of $312.56 billion, a P/E ratio of 14.95, a PEG ratio of 2.25 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company’s fifty day simple moving average is $303.65 and its two-hundred day simple moving average is $357.64.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s payout ratio is presently 38.30%.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Finally, Barclays lifted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.